Skip to content

Clinical trials

Bone Diseases, Metabolic trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bone Diseases, Metabolic Country / region: United Kingdom Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20042
20062
20081
20123
20132
20152
20171
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting4
Unknown status4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
Novartis Pharmaceuticals2
AO Innovation Translation Center1
Alphatec Spine, Inc.1
AstraZeneca1
Institut Straumann AG1
Ligand Pharmaceuticals1
Oxford Brookes University1
Promedius Inc1
Tameside General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bone Diseases, Metabolic19
Osteoporosis7
Bone Diseases2
Breast Neoplasms2
Hypophosphatemia2
Musculoskeletal Diseases2
Osteoporosis, Postmenopausal2
Ankylosis1
Anxiety Disorders1
Constriction, Pathologic1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.